19,524 Shares in Oscar Health, Inc. (NYSE:OSCR) Acquired by WealthPlan Investment Management LLC

Key Points

• WealthPlan Investment Management LLC has made a new investment of $256,000 in Oscar Health, purchasing 19,524 shares during the first quarter.
• Oscar Health recently reported a quarterly loss of $0.89 earnings per share, surpassing analysts' expectations of a $0.90 loss, while revenue increased by 29% year-over-year.
• Analysts have generally downgraded Oscar Health's stock, with five maintaining a sell rating and others reducing their price targets significantly.

WealthPlan Investment Management LLC bought a new stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 19,524 shares of the company's stock, valued at approximately $256,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Tempus Wealth Planning LLC increased its holdings in shares of Oscar Health by 6.7% in the first quarter. Tempus Wealth Planning LLC now owns 14,392 shares of the company's stock worth $189,000 after acquiring an additional 906 shares in the last quarter. Xponance Inc. boosted its position in shares of Oscar Health by 7.1% during the first quarter. Xponance Inc. now owns 15,423 shares of the company's stock worth $202,000 after buying an additional 1,029 shares during the period. CWM LLC boosted its position in shares of Oscar Health by 50.7% during the first quarter. CWM LLC now owns 3,204 shares of the company's stock worth $42,000 after buying an additional 1,078 shares during the period. Summit Investment Advisors Inc. boosted its position in shares of Oscar Health by 5.8% during the fourth quarter. Summit Investment Advisors Inc. now owns 20,838 shares of the company's stock worth $280,000 after buying an additional 1,141 shares during the period. Finally, Oppenheimer & Co. Inc. boosted its position in shares of Oscar Health by 4.6% during the first quarter. Oppenheimer & Co. Inc. now owns 28,362 shares of the company's stock worth $372,000 after buying an additional 1,250 shares during the period. 75.70% of the stock is owned by institutional investors and hedge funds.

Oscar Health Stock Performance

NYSE:OSCR traded down $0.43 on Tuesday, hitting $15.19. The company's stock had a trading volume of 9,295,702 shares, compared to its average volume of 13,225,880. The company has a current ratio of 0.86, a quick ratio of 0.86 and a debt-to-equity ratio of 0.26. The stock has a fifty day moving average of $15.93 and a two-hundred day moving average of $14.83. The firm has a market capitalization of $3.87 billion, a P/E ratio of -18.77 and a beta of 1.86. Oscar Health, Inc. has a one year low of $11.20 and a one year high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The company reported ($0.89) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.90) by $0.01. The firm had revenue of $2.86 billion for the quarter, compared to analyst estimates of $2.88 billion. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%. The business's revenue for the quarter was up 29.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.20 earnings per share. Research analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on OSCR. Raymond James Financial cut Oscar Health from an "outperform" rating to a "market perform" rating in a research report on Tuesday, June 24th. Piper Sandler cut Oscar Health from an "overweight" rating to a "neutral" rating and set a $14.00 price objective for the company. in a research report on Monday, July 14th. UBS Group reaffirmed a "sell" rating and set a $11.00 price objective (down from $15.00) on shares of Oscar Health in a research report on Tuesday, July 15th. Wall Street Zen cut Oscar Health from a "hold" rating to a "sell" rating in a research report on Saturday. Finally, Wells Fargo & Company cut Oscar Health from an "equal weight" rating to an "underweight" rating and reduced their price target for the company from $16.00 to $10.00 in a research report on Friday, July 11th. Six equities research analysts have rated the stock with a sell rating and four have assigned a hold rating to the company. According to data from MarketBeat.com, Oscar Health presently has a consensus rating of "Reduce" and an average price target of $12.21.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.